Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Excluding Restructuring Costs for Each, Operating Income Exceeds Earnings Guidance Company Completes FC1 to FC2 Transition Considers Payment of...
-
CHICAGO, Nov. 12, 2009 (GLOBE NEWSWIRE) -- The Female Health Company (Nasdaq:FHCO), today reported that a patent has been issued on its second generation product, FC2, by the European patent office....
-
CHICAGO, Oct. 21, 2009 (GLOBE NEWSWIRE) -- The Female Health Company (Nasdaq:FHCO), which manufactures and markets the FC Female Condom(R) (FC1) and FC2 Female Condom(R) (FC2), today reported that it...
-
CHICAGO, Sept. 8, 2009 (GLOBE NEWSWIRE) -- The Female Health Company (Nasdaq:FHCO) announced that it has signed a contract with John Snow, Inc.(JSI), for the supply of 12 million FC2 female condoms...
-
CHICAGO, Sept. 4, 2009 (GLOBE NEWSWIRE) -- The Female Health Company (Nasdaq:FHCO), which manufactures and markets the FC1 and FC2 Female Condom(r), today announced that the Company's CEO, O.B....
-
Operating Income Rises 275% to $1.5 Million Increases Earnings Guidance Third quarter highlights: * 275% Operating Profit increase to $1.5...
-
CHICAGO, July 7, 2009 (GLOBE NEWSWIRE) -- The Female Health Company (Nasdaq:FHCO) today announced that O.B. Parrish, its Chairman and CEO, will ring the NASDAQ Stock Market opening bell on Wednesday,...